Skip to Content

711 (Mesalamine delayed-release 1.2 g)

Pill with imprint 711 is Brown, Elliptical / Oval and has been identified as Mesalamine delayed-release 1.2 g. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of ulcerative colitis; ulcerative colitis, maintenance; crohn's disease; crohn's disease, maintenance; ulcerative proctitis (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substance Act (CSA).

Images for 711

Mesalamine delayed-release

Imprint:
711
Strength:
1.2 g
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
5-aminosalicylates
Pregnancy Category:
B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals (USA) Inc.
National Drug Code (NDC):
68382-0711

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide